Investor Presentaiton
QUARTERLY FINANCIAL SUMMARY
SEGMENTAL BREAKDOWN (INR Million)
Revenue Division
A) API Revenue
Q2FY24
Q1FY24
Q2FY23
FY23
FY22
778
751
441
2,103
2,481
B) Formulation
B1) Formulation - Exports (incl profit share, license income,
export service income & Subsidiaries)
7,923
8,842
2,834
20,632
11,842
B2) Formulation - Domestic
1,025
1,324
935
3,749
4,771
Formulations Total Revenue (B1 + B2)
8,948
10,166
3,769
24,381
16,612
c) Crop Health Sciences
558
447
30
409
51
D) Other Operating & Non - operating incomes
324
238
286
1,224
1,293
Consolidated Total Revenue
10,608
11,602
4,526
28,117
20,438
KEY FINANCIAL SUMMARY (INR Million)
Financial Summary
Q2FY24
Q1FY24
Q2FY23
FY23
FY22
Revenue
10,608
11,602
4,526
28,117
20,438
Earnings before Interest, Tax, Depreciation and Amortization
4,874
5,477
1,023
10,402
3,625
(EBITDA)
EBITDA Margin* (%)
45.9%
47.2%
22.6%
37.0%
17.7%
Profit After Tax (PAT)
3,690
4,203
568
7,153
1,700
PAT Margin (%)
34.8%
36.2%
12.5%
25.4%
8.3%
*includes other income
NATCO
13View entire presentation